Module 16 2024

21/10/2024

MDR Recital 74 - Manufacturers…

• should play an active role during the post-market phase

• systematically and actively gathering information from post-market experience

• update their technical documentation and cooperate with the national competent authorities

• establish a comprehensive post-market surveillance system, set up under their quality management system and based on a post-market surveillance plan. • Use relevant data and information gathered through post-market surveillance, lessons learned from any implemented preventive and corrective actions • to update any relevant part of technical documentation, such as those relating to risk assessment and clinical evaluation and should also serve the purpose of transparency.

© NAMSA 2023 | 3

3

PMCF…a continuous process

• The manufacturer shall proactively collect and evaluate clinical data with the aim of..

- confirming the safety and performance throughout the expected lifetime of the device

- ensuring the continued acceptability of identified risks and of detecting emerging risks on the basis of factual evidence

© NAMSA 2023 | 4

4

2